Literature DB >> 25565065

Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS).

Ronald C Chen1, William R Carpenter, Mimi Kim, Laura H Hendrix, Robert P Agans, Anne-Marie Meyer, Anna Hoffmeyer, Bryce B Reeve, Matthew E Nielsen, Deborah S Usinger, Tara S Strigo, Anne M Jackman, Mary Anderson, Paul A Godley.   

Abstract

The North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) was designed in collaboration with stakeholders to compare the effectiveness of different treatment options for localized prostate cancer. Using the Rapid Case Ascertainment system of the North Carolina Central Cancer Registry, 1,419 patients (57% of eligible) with newly-diagnosed localized prostate cancer were enrolled from January 2011 to June 2013, on average 5 weeks after diagnosis. All participants were enrolled prior to treatment and this population-based cohort is sociodemographically diverse. Prospective follow-up continues to collect data on treatments received, disease control, survival and patient-reported outcomes. This study highlights several important considerations regarding stakeholder involvement, study design and generalizability regarding comparative effectiveness research in prostate cancer.

Entities:  

Keywords:  brachytherapy; comparative effectiveness research; prostate cancer; prostatectomy; radiation

Mesh：

Year:  2015        PMID： 25565065     DOI： 10.2217/cer.14.67

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN： 2042-6305            Impact factor:   1.744


  17 in total

1.  Psychometric Evaluation of PROMIS Sexual Function and Satisfaction Measures in a Longitudinal Population-Based Cohort of Men With Localized Prostate Cancer.

Authors:  Bryce B Reeve; Mian Wang; Kevin Weinfurt; Kathryn E Flynn; Deborah S Usinger; Ronald C Chen
Journal:  J Sex Med       Date:  2018-10-24       Impact factor: 3.802

2.  Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study.

Authors:  Caroleen W Quach; Michelle M Langer; Ronald C Chen; David Thissen; Deborah S Usinger; Marc A Emerson; Bryce B Reeve
Journal:  Qual Life Res       Date:  2016-05-30       Impact factor: 4.147

3.  Involvement in Decision Making and Satisfaction With Treatment Among Partners of Patients With Newly Diagnosed Localized Prostate Cancer

Authors:  Yael Symes; Lixin Song; Rachael G Heineman; Brittney D Barbosa; Kimberly Tatum; Giselle Greene; Mark Weaver; Ronald C Chen
Journal:  Oncol Nurs Forum       Date:  2015-11       Impact factor: 2.172

4.  Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Authors:  Kathryn L Taylor; George Luta; Richard M Hoffman; Kimberly M Davis; Tania Lobo; Yingjun Zhou; Amethyst Leimpeter; Jun Shan; Roxanne E Jensen; David S Aaronson; Stephen K Van Den Eeden
Journal:  Transl Behav Med       Date:  2018-03-01       Impact factor: 3.046

5.  Symptom and function profiles of men with localized prostate cancer.

Authors:  Bryce B Reeve; Xianming Tan; Ronald C Chen; Deborah S Usinger; Laura C Pinheiro
Journal:  Cancer       Date:  2018-04-16       Impact factor: 6.860

6.  eHealth Literacy and Partner Involvement in Treatment Decision Making for Men With Newly Diagnosed Localized Prostate Cancer

Authors:  Lixin Song; Kimberly Tatum; Giselle Greene; Ronald C Chen
Journal:  Oncol Nurs Forum       Date:  2017-03-01       Impact factor: 2.172

7.  Evaluating measurement invariance across assessment modes of phone interview and computer self-administered survey for the PROMIS measures in a population-based cohort of localized prostate cancer survivors.

Authors:  Mian Wang; Ronald C Chen; Deborah S Usinger; Bryce B Reeve
Journal:  Qual Life Res       Date:  2017-07-05       Impact factor: 4.147

8.  Patient-reported sexual quality of life after different types of radical prostatectomy and radiotherapy: Analysis of a population-based prospective cohort.

Authors:  Brandon T Mullins; Ramsankar Basak; James R Broughman; Ronald C Chen
Journal:  Cancer       Date:  2019-06-30       Impact factor: 6.860

9.  Factors influencing prostate cancer treatment decisions for African American and white men.

Authors:  Brittaney-Belle E Gordon; Ramsankar Basak; William R Carpenter; Deborah Usinger; Paul A Godley; Ronald C Chen
Journal:  Cancer       Date:  2019-01-29       Impact factor: 6.860

10.  Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate Cancer.

Authors:  Dominic H Moon; Ram S Basak; Deborah S Usinger; Gregg A Dickerson; David E Morris; Mark Perman; Maili Lim; Turner Wibbelsman; Jerry Chang; Zachary Crawford; James R Broughman; Paul A Godley; Ronald C Chen
Journal:  Eur Urol       Date:  2019-03-08       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.